Immunogenomics of unrelated hematopoietic cell transplantation.
The MHC on human chromosome 6p21 encodes the HLA genes that govern histocompatibility in transplantation. Selection of potential unrelated volunteer donors for hematopoietic cell transplantation has required an understanding of the role of HLA gene products in mediating graft-versus-host and host-versus-graft alloreactions that give rise to the 'transplantation barrier'. Recent advances in the immunogenomics of the MHC in unrelated hematopoietic cell transplantation have been made through systemic examination of the alleles and antigens of large populations of racially and ethnically diverse transplant donors and recipients. The importance of non-HLA MHC-resident genetic variation in clinical outcome is increasingly being recognized. These data show that clinical outcome following transplantation is shaped by the combined effects of many genes within the MHC and their sequence polymorphisms.
Petersdorf
Effie W
EW
University of Washington, Fred Hutchinson Cancer Research Center, D4-100, Seattle, WA 98109, USA. epetersd@fhcrc.org
D006086:Graft vs Host Disease / Q000276:immunology; D006680:HLA Antigens / Q000235:genetics / Q000276:immunology; D006239:Haplotypes; D018380:Hematopoietic Stem Cell Transplantation; D006801:Humans; D007125:Immunogenetics; D008285:Major Histocompatibility Complex; D011110:Polymorphism, Genetic; D023001:Transplantation Tolerance / Q000235:genetics / Q000276:immunology; D014184:Transplantation, Homologous
D006680:HLA Antigens